PFIZER INC Other Long-term Investments
PFIZER INC (PFE) had Other Long-term Investments of $1.56 billion as of 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:OtherLongTermInvestments · last filed 2026-08-04
- 2026-06-28: Other Long-term Investments $1.56B.
- 2026-03-29: Other Long-term Investments $1.63B.
- 2025-12-31: Other Long-term Investments $1.62B.
- 2025-09-28: Other Long-term Investments $2.14B.
| Period end | Other Long-term Investments | Other Long-term Investments as first filed |
|---|---|---|
| 2026-06-28 | $1.56B 10-Q · filed 2026-08-04 | |
| 2026-03-29 | $1.63B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $1.62B 10-Q · filed 2026-08-04 | |
| 2025-09-28 | $2.14B 10-Q · filed 2025-11-04 | |
| 2025-06-29 | $1.90B 10-Q · filed 2025-08-05 | |
| 2025-03-30 | $1.79B 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $2.23B 10-K · filed 2026-02-26 | $2.01B 10-K · filed 2025-02-27 |
| 2024-09-29 | $2.18B 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $3.12B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $3.49B 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.73B 10-K · filed 2025-02-27 | |
| 2023-10-01 | $3.21B 10-Q · filed 2023-11-08 | |
| 2023-07-02 | $3.64B 10-Q · filed 2023-08-09 | |
| 2023-04-02 | $3.57B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $4.04B 10-K · filed 2024-02-22 | |
| 2022-10-02 | $4.06B 10-Q · filed 2022-11-09 | |
| 2022-07-03 | $4.16B 10-Q · filed 2022-08-10 | |
| 2022-04-03 | $4.74B 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $5.05B 10-K · filed 2023-02-23 | |
| 2021-10-03 | $5.25B 10-Q · filed 2021-11-12 | |
| 2021-07-04 | $4.33B 10-Q · filed 2021-08-12 | |
| 2021-04-04 | $3.70B 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.41B 10-K · filed 2022-02-24 | |
| 2020-09-27 | $3.06B 10-Q · filed 2020-11-05 | |
| 2020-06-28 | $3.14B 10-Q · filed 2020-08-06 | |
| 2020-03-29 | $2.70B 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.01B 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |